<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Drugs - Generic Industry News</title><link>http://biz.yahoo.com/ic/news/512.html</link><description>The latest news on the Drugs - Generic industry from Yahoo! Finance</description><language>en-US</language><lastBuildDate>Sat, 26 May 2012 13:02:00 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title></title><link></link><width>144</width><height>45</height></image><item><title>Rosen Law Firm Files Class Action Against Tibet Pharmaceuticals, Inc. – TBET</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/rosen-law-firm-files-class-130200529.html</link><description>[Business Wire] - The Rosen Law Firm, P.A. today announced that it has filed a class action lawsuit on behalf of investors who purchased the securities of Tibet Pharmaceuticals, Inc. (“Tibet Pharma”</description><guid isPermaLink="false">yahoo_finance/1267059231</guid><pubDate>Sat, 26 May 2012 13:02:00 GMT</pubDate></item><item><title>Medicis Sued by Revance Therapeutics Over Wrinkle-Gel Pact</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=13dctop2t/*http://www.bloomberg.com/news/2012-05-25/medicis-sued-by-revance-therapeutics-over-wrinkle-gel-pact-1-.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/2165100522</guid><pubDate>Fri, 25 May 2012 21:34:17 GMT</pubDate></item><item><title>Watson to Present at the Jefferies 2012 Global Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/watson-present-jefferies-2012-global-131500839.html</link><description>[PR Newswire] - PARSIPPANY, N.J., May 25, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty global pharmaceutical company, announced today that Siggi Olafsson, Watson&apos;s President of Global ...</description><guid isPermaLink="false">yahoo_finance/1331691011</guid><pubDate>Fri, 25 May 2012 13:15:00 GMT</pubDate></item><item><title>Depressed From Recent News, Myrexis&apos; Presentation At ASCO Draws Speculation</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13iidic02/*http://seekingalpha.com/article/617441-depressed-from-recent-news-myrexis-presentation-at-asco-draws-speculation?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/878403175</guid><pubDate>Fri, 25 May 2012 07:53:16 GMT</pubDate></item><item><title>UPDATE 1-Mylan settles patent suit over Sunovion&apos;s lung drug</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12dsqj451/*http://www.reuters.com/article/2012/05/24/mylan-brief-idUSL4E8GOBQN20120524?feedType=RSS&amp;feedName=governmentFilingsNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/141406937</guid><pubDate>Thu, 24 May 2012 22:37:49 GMT</pubDate></item><item><title>Sunovion Settles Patent Dispute With Mylan Over Brovana</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=137tc0foe/*http://www.bloomberg.com/news/2012-05-24/sunovion-settles-patent-dispute-with-mylan-over-brovana.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/3389846891</guid><pubDate>Thu, 24 May 2012 22:35:41 GMT</pubDate></item><item><title>Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion&apos;s Brovana® Product</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/mylan-announces-settlement-agreement-patent-213300384.html</link><description>[PR Newswire] - PITTSBURGH, May 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a ...</description><guid isPermaLink="false">yahoo_finance/3299290065</guid><pubDate>Thu, 24 May 2012 21:33:00 GMT</pubDate></item><item><title>Watson Confirms Testim® Patent Challenge</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/watson-confirms-testim-patent-challenge-200500098.html</link><description>[PR Newswire] - PARSIPPANY, N.J., May 24, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) ...</description><guid isPermaLink="false">yahoo_finance/3405792465</guid><pubDate>Thu, 24 May 2012 20:05:00 GMT</pubDate></item><item><title>Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/mylan-launches-generic-version-bonviva-172600648.html</link><description>[PR Newswire] - PITTSBURGH, POTTERS BAR, England and MILAN, May 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its UK and Italy-based subsidiaries have launched Ibandronic Acid Film Coated Tablets ...</description><guid isPermaLink="false">yahoo_finance/1741379543</guid><pubDate>Thu, 24 May 2012 17:26:00 GMT</pubDate></item><item><title>Watson Pharma rises on Wells Fargo analyst upgrade</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/watson-pharma-rises-wells-fargo-171022032.html</link><description></description><guid isPermaLink="false">yahoo_finance/2653671714</guid><pubDate>Thu, 24 May 2012 17:10:22 GMT</pubDate></item><item><title>Teva Pharmaceuticals: The Bottom Is Finally In For These Beaten Down Shares</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13juml9d4/*http://seekingalpha.com/article/615551-teva-pharmaceuticals-the-bottom-is-finally-in-for-these-beaten-down-shares?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/314092484</guid><pubDate>Thu, 24 May 2012 15:19:43 GMT</pubDate></item><item><title>Catalyst Pharmaceutical Partners Prices Underwritten Offering</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/catalyst-pharmaceutical-partners-prices-underwritten-124500844.html</link><description>[GlobeNewswire] - CORAL GABLES, Fla. -- Catalyst Pharmaceutical Partners, Inc. today announced the pricing of an underwritten offering of 6,000,000 units, with each unit consisting of one share of its common stock and a ...</description><guid isPermaLink="false">yahoo_finance/4283803529</guid><pubDate>Thu, 24 May 2012 12:45:00 GMT</pubDate></item><item><title>Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/merck-mylan-look-benefit-plan-122000130.html</link><description>[Marketwire] - NEW YORK, NY-- - Lost revenues as a result of expiring patents have been a growing problem for the big pharmaceutical companies. New products that are being introduced into the market place are not expected ...</description><guid isPermaLink="false">yahoo_finance/4032142408</guid><pubDate>Thu, 24 May 2012 12:20:00 GMT</pubDate></item><item><title>Has Momenta Pharmaceuticals Become the Perfect Stock?</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=139oshkeg/*http://www.fool.com/investing/general/2012/05/22/has-momenta-pharmaceuticals-become-the-perfect-st.aspx?ticker=WPI&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2492058908</guid><pubDate>Thu, 24 May 2012 00:04:02 GMT</pubDate></item><item><title>Teva Tumbles on Morgan Stanley Doubts: Israel Overnight</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=1367b16cf/*http://www.bloomberg.com/news/2012-05-23/teva-tumbles-on-morgan-stanley-doubts-israel-overnight.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/3820046550</guid><pubDate>Wed, 23 May 2012 23:44:12 GMT</pubDate></item><item><title>Moody&apos;s Upgrades Mylan</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/moodys-upgrades-mylan-173400663.html</link><description>[PR Newswire] - PITTSBURGH, May 23, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today reported that Moody&apos;s Investors Service (&quot;Moody&apos;s&quot;) has upgraded the company&apos;s credit ratings, including the &quot;Corporate ...</description><guid isPermaLink="false">yahoo_finance/1832905344</guid><pubDate>Wed, 23 May 2012 17:34:00 GMT</pubDate></item><item><title>BRIEF - Moody&apos;s raises Mylan Inc rating to Ba1</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=11vktq580/*http://www.reuters.com/article/2012/05/23/idUSWNA794120120523?type=companyNews&amp;feedType=RSS&amp;feedName=companyNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/4160989478</guid><pubDate>Wed, 23 May 2012 17:28:25 GMT</pubDate></item><item><title>Mylan Launches Generic Version of Viramune® Tablets</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/mylan-launches-generic-version-viramune-154200465.html</link><description>[PR Newswire] - PITTSBURGH, May 23, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) ...</description><guid isPermaLink="false">yahoo_finance/3541373756</guid><pubDate>Wed, 23 May 2012 15:42:00 GMT</pubDate></item><item><title>Merck: Manufacturing Portfolio Health With Dividend Income</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1324gv1eh/*http://seekingalpha.com/article/608321-merck-manufacturing-portfolio-health-with-dividend-income?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3926858653</guid><pubDate>Tue, 22 May 2012 13:35:32 GMT</pubDate></item><item><title>Galectin Therapeutics to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Shareholders</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/galectin-therapeutics-hold-conference-call-130000068.html</link><description>[Business Wire] - Galectin Therapeutics will host a conference call at 10:00 A.M. Eastern Time on Thursday, May 24, 2012, to provide an update following the Company’s Annual Meeting of Shareholders.</description><guid isPermaLink="false">yahoo_finance/987053672</guid><pubDate>Tue, 22 May 2012 13:00:00 GMT</pubDate></item><item><title>Catalyst Pharmaceutical Partners Reports Positive Results From Phase I(a) Clinical Study of CPP-115</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/catalyst-pharmaceutical-partners-reports-positive-120300588.html</link><description>[GlobeNewswire] - CORAL GABLES, Fla. -- Catalyst Pharmaceutical Partners, Inc. today announced positive results from a Phase I(a) study to evaluate the safety, tolerability and pharmacokinetic (PK) profile of CPP-115, a ...</description><guid isPermaLink="false">yahoo_finance/2232026107</guid><pubDate>Tue, 22 May 2012 12:03:00 GMT</pubDate></item><item><title>NTRR Orders Initial Manufacturing Run of New pH Balance Formulas</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ntrr-orders-initial-manufacturing-run-090000991.html</link><description></description><guid isPermaLink="false">yahoo_finance/901122337</guid><pubDate>Tue, 22 May 2012 09:00:00 GMT</pubDate></item></channel></rss><!-- c20.finance.sp2.yahoo.com compressed/chunked Tue May 29 01:48:21 UTC 2012 -->

